osteoporosis
OSTEOPOROSIS
Osteoporosis is the progressive, systemic skeletal disease characterized by decreased bone mass and micro-architectural deterioration of bone tissue leading to increased bone fragility and susceptibility to fractures.
The more risk factors (eg history, of fracture, advanced age, comorbidities, impaired vision) that are present, the greater the risk of fracture.
Drug Information

Indication: Treatment & prevention of vit D deficiency. Adjunctive treatment for osteoporosis. Reduces risk of falling...

Indication: Correction of combined vit D & Ca deficiency in the elderly. Adjunct to treatment of osteoporosis in patie...

Indication: Osteoporosis in postmenopausal women & prevents fractures in men.

Indication: Testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clin...

Indication: Postmenopausal osteoporosis. Reduce risk of vertebral & hip fractures.

Indication: Postmenopausal osteoporosis, to reduce the risk of fractures.

Calcium with Vitamin D Plus YSP
calcium carbonate + vitamin D

Indication: Dietary supplement.

Calcium with Vitamin D YSP
calcium + vitamin D3

Indication: Prevention of Ca deficiency.

1  /  6
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
14 Dec 2017
The coexistence of fibromyalgia in patients with axial spondyloarthritis (axSpA) exerts a negative effect on response to tumour necrosis factor blocker, according to a study. This effect appears to be associated with the self-reported instruments used in fibromyalgia evaluation rather than a different treatment effect of the agent in this population.